Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing
Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
Who this might be right for
Breast Cancer
National Cancer Institute (NCI)